Home | Login | Join | Sitemap | °ü¸®ÀÚ¿¡°Ô
  • ÇÐȸ ¼Ò°³
  • Á¶Á÷µµ
  • ÀÓ¿øÁø
  • ¿ª´ëÀÓ¿øÁø
  • ÆòÀÇ¿ø
  • ÇÐȸ ȸĢ
  • Çмú´ëȸ ¾È³»
  • °ü·Ã Çà»ç ¾È³»
  • Çмú´ëȸ ¿¬Çõ
  • Çмú´ëȸ ÀÚ·á
  • Åõ°í±ÔÁ¤
  • ³í¹®Åõ°í
  • ÇÐȸÁö °Ë»ö
  • ÇÐȸ ¼Ò½ÄÁö
  • ÀϹÝÀÎÀ» À§ÇÑ Áúȯ Á¤º¸
  • ±âŸÀÚ·á½Ç
  • º´¿ø ã±â
  • ÇÐȸ ¼Ò½Ä
  • ȸ¿ø °Ô½ÃÆÇ
  • ȸ¿ø ÀÚ·á½Ç
  • À§¿øȸ °ø°£
  • ȸ¿ø °Ë»ö
  • ÇÐȸ ¾Ù¹ü
Åõ°í±ÔÁ¤
³í¹®Åõ°í
ÇÐȸÁö °Ë»ö
- ÇÐȸÁö »ó¼¼°Ë»ö
- ÇÐȸÁö ±ÇÈ£º°°Ë»ö
ÇÐȸ ¼Ò½ÄÁö
HOME > °£Ç๰ > ÇÐȸÁö °Ë»ö
Korean Journal of Neuromuscular Disorders ; 2 : 26 - 29, July 2010
Diagnostic Role of Serum VLCFA Concentration: Application in a Patient with Uncomplicated Spastic Paraplegia
Down
Minho Hwang, MD, Byung-Kun Kim, MD, Jong-Moo Park, MD, JungJu Lee, MD, Kyusik Kang, MD, Ohyun Kwon, MD
Department of Neurology, Eulji Hospital,Eulji University College of Medicine, Seoul, Korea

A wide variety of pathologies could cause spastic paraplegia. It is often a diagnostic challenge to
pinpoint its cause, especially when lacks other discriminating clinical features. Biochemical studies,
especially very long-chain fatty acids (VLCFA), have invariably the ranges of estimates overlapping
for both groups of patient and healthy control. Here we present a patient with uncomplicated spastic
paraplegia who showed modest elevation of saturated VLCFA concentration.

KEYWORDS : Fatty acids, Spastic paraplegia

°Ô½Ã¹°¸ñ·ÏÀ» º¾´Ï´Ù.
(03163) ¼­¿ï Á¾·Î±¸ Àλ絿±æ 12, 1111È£ (Àλ絿, ´ëÀϺôµù)
TEL : 02-720-1594 E-mail : knmd1594@daum.net
Copyright©The Korean Society of Neuromuscular Disorders
TODAY 38 TOTAL 545802